Enovis ENOV
NYSE ENOV
$19.02 -0.96 (-4.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Enovis (ENOV) Other Operating Expenses (2022)

Enovis' (ENOV) quarterly Other Operating Expenses came in at $4.6 million in Q4 2022, up 571.79% quarter-over-quarter from -$975000.0 in Q3 2022.

Analysis

Enovis (ENOV) Other Operating Expenses (2022) Analysis & Trends

Enovis (ENOV) has reported Other Operating Expenses for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2022.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $4.6 million in Q4 2022; TTM through Sep 2023 was $4.6 million, a 85.65% decrease from a year earlier, with the FY2022 full-year figure at $36.7 million, changed N/A from the prior year.
  • Other Operating Expenses was $4.6 million for Q4 2022 at Enovis, up from -$975000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $33.0 million in Q3 2022 and troughed at -$975000.0 in Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.60 Mn
Sep 30, 2022 -975,000.00
Jul 1, 2022 33.03 Mn